Phenethylamine
Phenethylamine is the simplest compound of its namesake chemical class, a naturally occurring stimulant found throughout nature in both plants and animals, including as a notable component of chocolate.citation needed It is closely related structurally to amphetamine and several neurotransmitters.1 Despite its intrinsic stimulant properties, phenethylamine is rapidly and completely metabolized in the human body, which largely prevents it from expressing meaningful pharmacological activity when consumed on its own.citation needed
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
It is functionally inactive without a monoamine oxidase B inhibitor2, but combining it with a MAO-B inhibitor is quite risky and may rapidly lead to overdose.
Duration
Subjective Effects
Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.
Phenethylamine is notable for producing essentially no subjective effects when taken on its own, despite being intrinsically a stimulant. Human trials at oral doses of up to 1,600 mg and intravenous doses of up to 50 mg reported no effects whatsoever. This inactivity is attributed to its rapid and complete metabolism in the body, primarily by monoamine oxidase, which destroys the compound before its stimulant properties can be expressed.
Pharmacology
Pharmacodynamics
Phenethylamine acts as a releasing agent of norepinephrine and dopamine, with in vitro potency at these targets roughly comparable to amphetamine.citation needed It is a potent agonist at trace amine-associated receptor 1 (TAAR1)1 and inhibits vesicular monoamine transporter 2 (VMAT2) in monoamine neurons.citation needed In addition to its catecholamine-releasing activity, phenethylamine functions as a monoaminergic activity enhancer, increasing the action potential-mediated release of serotonin, norepinephrine, and dopamine at concentrations lower than those required for direct catecholamine release.
Pharmacokinetics
Phenethylamine is extremely rapidly metabolized, with an oral half-life of only 5 to 10 minutes. A significant portion of orally ingested phenethylamine is degraded in the small intestine by monoamine oxidase B (MAO-B) followed by aldehyde dehydrogenase (ALDH), producing phenylacetic acid as the primary urinary metabolite. Additional metabolizing enzymes in humans include MAO-A, phenylethanolamine N-methyltransferase (PNMT), the semicarbazide-sensitive amine oxidases AOC2 and AOC3, flavin-containing monooxygenase 3 (FMO3),citation needed and aralkylamine N-acetyltransferase (AANAT). This extensive and rapid enzymatic breakdown accounts for phenethylamine's negligible oral psychoactivity under normal conditions, though activity can emerge in the presence of a monoamine oxidase inhibitor.
Interactions
An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.
Tolerance
Harm Potential
Addiction & Dependence
Psychological
Phenethylamine is pharmacologically inactive when taken alone due to rapid metabolism by monoamine oxidase.citation needed Misuse in combination with MAO inhibitors has been reported, though abuse potential is not well characterized.
Toxicity
Acts as a potent antimicrobial against certain pathogenic strains of Escherichia coli, including the O157:H7 strain, at sufficient concentrations.citation needed
History & Culture
Phenethylamine has long held a special place in psychopharmacological research due to its status as the simplest member of the phenethylamine chemical class. Its clean molecular structure, natural presence in human tissues and bodily fluids, and close chemical relationship to both amphetamine and…
Legality
By Country
References
Source Pages
Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding.
DrugBank: Phenethylamine
DrugBank: Phenethylamine BioEntity
Erowid: PiHKAL Entry #142 PEA
Isomer Design (TiHKAL/PiHKAL)
PsychonautWiki: Phenethylamine (compound)
TripSit Factsheet: Phenethylamine
Wikipedia
Wikipedia: TAAR1
Citations
- Yue Pei, Aman Asif-Malik, & Juan J. Canales. (April 2016). Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications. Frontiers in Neuroscience, 10, 148. https://doi.org/10.3389/fnins.2016.0014812
- J. Bergman, S. Yasar, & G. Winger. (2001). Psychomotor stimulant effects of β-phenylethylamine in monkeys treated with MAO-B inhibitors. https://doi.org/10.1007/s0021301008901
- Robinson JC, & Snyder HR. (1955). β-Phenylethylamine. Organic Syntheses, Collected Volume, 3, 720. https://www.orgsyn.org/demo.aspx?prep=CV3P07201
- 2026年兴奋剂目录公告(2025年第6号). sport.gov.cn (n.d.). https://www.sport.gov.cn/n315/n9041/n25319615/n25319760/c29452070/part/29454124.pdf1
- 2026年兴奋剂目录公告(2025年第6号). samr.gov.cn (n.d.). https://www.samr.gov.cn/zw/zfxxgk/fdzdgknr/bgt/art/2023/art_ab59ecfc91ce456399fcf3357ea54622.html1
- Resolución 116 de 2026. minsalud.gov.co (n.d.). https://www.minsalud.gov.co/Normatividad_Nuevo/Resolucion%20No%20116%20de%202026.pdf1
- Resolución 116 de 2026. normograma.invima.gov.co (n.d.). https://normograma.invima.gov.co/normograma/compilacion/docs/resolucion_minsaludps_0315_2020.htm1
- Resolución 116 de 2026. suin-juriscol.gov.co (n.d.). https://www.suin-juriscol.gov.co/viewDocument.asp?ruta=Leyes%252F16632301
- Act No. 167/1998 Coll., on Addictive Substances (§ 2); Government Regulation No. 463/2013 Coll., on Lists of Addictive Substances. mzd.gov.cz (n.d.). https://mzd.gov.cz/wp-content/uploads/2025/10/Sb_1998_167_2026-01-01_IZ.pdf1
- Act No. 167/1998 Coll., on Addictive Substances (§ 2); Government Regulation No. 463/2013 Coll., on Lists of Addictive Substances. e-sbirka.gov.cz (n.d.). https://e-sbirka.gov.cz/sb/1998/167/2025-07-011
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed — this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Recent changes8 human edits · latest
Times are UTCNewest first
14 August 2026
Lyrea · Updated the article
24 January 2026
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the Phenethylamine article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.